Tender notice from Bulgaria, published on 26 Apr 2018.
Executive Summary
The ?????????? ??????????? ?????? — ??????? has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 26 Apr 2018 and is scheduled to close on 30 May 2018, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 22803081, while the tender notice number is 180830-2018 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Body governed by public law Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33621000, 33600000, 33621000, 33642000, 33642200, 33652100, 33652200, 33652000, 33690000, 33632000, 33661000 CPV Description: Pharmaceutical products. Medicinal products for the blood and blood-forming organs. Systemic hormonal preparations, excl. sex hormones. Corticosteroids for systemic use. Antineoplastic agents. Endocrine therapy medicinal products. Antineoplastic and immunomodulating agents. Various medicinal products. Medicinal products for the musculo-skeletal system. Medicinal products for the nervous system. Доrate of oncological medicinal products for the needs of "Complex Oncology Center Plovdiv" Ltd. by lots - The subject of the public procurement covers periodic supplies of oncological medicinal products for the needs of "KOT - Plovdiv" Ltd. in accordance with the technical specifications and the models of the technical and price proposal, an integral part of the public documentationorder. The order is divided into eighty-five distinct positions described in this notice. "Alexander Stamboliyski" № 2 A, hospital pharmacy of "KOT - Plovdiv" EOOD Periodic supplies of a medicinal product with international non-proprietary name / INN / Darbepoetin alfa 300 mcg Approximately for a period of one year 60 000 mcg. The participant owns the Allowfor the manufacture / wholesale / import of / medicinal products issued by the BDA or by a regulatory body of another EU Member State under Chapter Nine: "Wholesale of medicinal products and mediation in the field of medicinal products" by LMPHM The participant shall hold a license under Article 32 of the Narcotic Substances and Precursors Control Act in cases where theThe presence of a valid authorization for the manufacture / wholesale / import of / with medicinal products issued by the BDA or by a regulatory body of another EU Member State under Chapter Nine: "Trade wholesale of medicinal products and mediation in the field of medicinal products "by LMPHM is presented in the form of-If the participant holds a wholesale license issued by a regulatory body of another EU member state, he must submit: - Permission by the Executive Director of BDA in the cases under Art. 195, para. 2 of LMPHM - copy certified by the participant. License under Art. 32 of the Control of Narcotic Substances and Precursors Act in cases where a bidthe participant presents drugs and precursors are presented in the form of a certified copy.- When submitting the tender, the participant declares the compliance with the selection criterion by submitting the EEDOP .. The documents referred to above are also submitted to the subcontractors in case that the participant provides for such, according to the type and the share of the order they will executea party to the procedure is an association which is not a legal person, the documents are submitted by any natural or legal person included in the grouping according to the distribution of the participation of the persons in the performance of the activities provided for in the contract establishing the grouping. above, to demonstrate compliance with the requested requirement shall be provided by the participant, for the contractor or on request in the course of the procedure under Art. 67, para. 5 and 6 of the Public Procurement Act. The Contracting Authority does not specify selection criteria regarding the economic and financial status of the participants .. The assignor removes from participation in the procedure / separate participant: 1. For whom are the grounds under Art. 54, para. 1 and the circumstances under Art. 55, para. 1, items 1, 4, 5 of the PPAs that occurred before or during the procedure; For whom are the grounds under Art. 107 of the Public Procurement Act; Whoever is not entitled to participate in public procurement on the grounds of Art. 3, item 8 of the Economic and Financial Relations Act with the companies registered in preferential tax jurisdictions, the persons controlled by them and their actual owners (ЗИФОДЮРРКЛТДС), besideswhen the conditions under Art. 4 of the law. The grounds under Art. 54, para. 1, items 1, 2 and 7 and Art. 54, para. 1, item 5 of the Public Procurement Act shall apply to the persons under Art. 40 of the RSPC. The requirement under Art. 54, para. 1, item 3 of the Public Procurement Act shall not apply where the amount of unpaid taxes or social security contributions is not more than 1 per cent of the sum of the annual total turnover for the last completed financial year. Ohthe remedies under paragraph 1 shall be applied until the expiry of the terms under Art. 57, para. 3 of the PPA. The grounds for removal are also applicable to subcontractors and third parties. Where one of the grounds under Art. 54, para. 1 and Art. 55, para. 1, items 1, 4, 5 of the Public Procurement Act and before taking a tender he has taken measures for proving the reliability under Art. 56 of the PPA, these measures are described in EEDOP, but as evidence of reliability of the participant shall be presented the documents under Art. 45, para. It is envisaged that the concluded contracts will be renewed under the same conditions for a period of 6 months, with a volume and a forecast value of one second according to the stipulated condition in Art. 17, para. 2 of the draft contract. In connection with this possibility and on the grounds of Art. 21, para. 1 of the Public Procurement Act referred to in this noticethe contract (s) concluded for the award of this contract may be one-time renewal within the meaning of Art. 6, para. 1 of the PPPP, on the initiative of the contracting authority, in the presence of financial resources and necessity of deliveries of the goods, subject to the contract; renewal may be initiated by the assignor when the circumstance occurswith the expiry of the agreed term or with the total estimated value of the supplies; the renewal shall include the repetition of all activities under the subject matter of the contract under the same conditions for a period of six (six) months, volume and total value - one-half of the estimated value of the contract; the renewal shall be effected only upon a written letter from the contracting authority to the executionin which the start date of execution is indicated. The renewal letter of intent becomes an integral part of the contract. The guarantee for the performance of the contract amounts to 0.5% (zero percent and five percent) of the contract value excluding VAT. The selected contractor shall choose the form of the performance guarantee under Art. 111, para. 5 of the Public Procurement Act Offers may be submitted for onehow many or all of the items in the order. On grounds of Art. 47, para. 10 of the RPSP, in the case of participation in more than one lot, the contracting authority allows the submission of one application for participation - documents under Art. 39, para. 2 of the PPP Internet address (URL): http://www.onkoplov.com/ Directive: Classical Directive (2014/24/EU)
The bid deadline for Contract notice: Pharmaceutical products was 30 May 2018. Bidding is closed.
This tender has been issued by ?????????? ??????????? ?????? — ??????? in Bulgaria.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33621000 - Medicinal products for the blood and blood-forming organs, 33642000 - Systemic hormonal preparations, excl. sex hormones, 33642200 - Corticosteroids for systemic use, 33652100 - Antineoplastic agents, 33652200 - Endocrine therapy medicinal products, 33652000 - Antineoplastic and immunomodulating agents, 33690000 - Various medicinal products, 33632000 - Medicinal products for the musculo-skeletal system, 33661000 - Medicinal products for the nervous system.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 22803081. The purchaser document reference is 180830-2018.